VBU
Clozapine
| Created: | 2023-07-14 |
| Last modified: | 2024-11-12 |
Find Related PDB Entry |
|---|
Find related ligands:Help |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 42 |
| Chiral Atom Count | 0 |
| Bond Count | 45 |
| Aromatic Bond Count | 12 |
Chemical Component Summary | |
|---|---|
| Name | Clozapine |
| Synonyms | 3-chloranyl-6-(4-methylpiperazin-1-yl)-11~{H}-benzo[b][1,4]benzodiazepine |
| Systematic Name (OpenEye OEToolkits) | 3-chloranyl-6-(4-methylpiperazin-1-yl)-11~{H}-benzo[b][1,4]benzodiazepine |
| Formula | C18 H19 Cl N4 |
| Molecular Weight | 326.823 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | CACTVS | 3.385 | CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24 |
| SMILES | OpenEye OEToolkits | 2.0.7 | CN1CCN(CC1)C2=Nc3cc(ccc3Nc4c2cccc4)Cl |
| Canonical SMILES | CACTVS | 3.385 | CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24 |
| Canonical SMILES | OpenEye OEToolkits | 2.0.7 | CN1CCN(CC1)C2=Nc3cc(ccc3Nc4c2cccc4)Cl |
| InChI | InChI | 1.06 | InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3 |
| InChIKey | InChI | 1.06 | QZUDBNBUXVUHMW-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB00363 |
|---|---|
| Name | Clozapine |
| Description | A tricyclic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. |
| Synonyms |
|
| Indication | For use in patients with treatment-resistant schizophrenia. |
| Categories |
|
| ATC-Code | N05AH02 |
| CAS number | 5786-21-0 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Dopamine D2 receptor | MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVF... | unknown | antagonist |
| 5-hydroxytryptamine receptor 2A | MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSE... | unknown | antagonist |
| Dopamine D1 receptor | MRTLNTSAMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIR... | unknown | antagonist |
| Dopamine D3 receptor | MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLV... | unknown | antagonist |
| Dopamine D4 receptor | MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLA... | unknown | antagonist |
| View More | |||
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL42 |
| PubChem | 135398737 |
| ChEMBL | CHEMBL42 |
| ChEBI | CHEBI:3766, CHEBI:92657 |
| CCDC/CSD | DEHBUP, NDNHCL10 |
